Various recent studies have indicated the great significance of aberrant ERβ expression in human glioma, its decreasing expression in high-grade tumors, and the inhibitory effect of ERβ agonist on the proliferation of glioblastoma cell lines [12, 21]. Here, ESR2 is linked to central nervous system cancer.